Showing 55 results

Environmental Impact Assessment for landfill expansion

Management Plan for Water Resources in the Baia de Guanabara

Webcapture from a recent training course (Nov 2020) held at the EBI (European Institute of Bioinformatics) that includes Phyre – open to academia and industry

Print out of Google Analytics for access to Phyre

Press release from Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product

Press release from Neuroprotexeon on the European Distribution Partnership between NeuroproteXeon and Linde

Results from the Phase 1 Trials - Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study

Funding for a second trial

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial

Award of EU-FP7 funding to Alkion BioPharma as part of TriForC consortium working on the commercialization of terpenoids

Product webpage for ‘Apple of Sodom’ sold by Ahava

Alkion BioInnovations and its awards

OIE listing of Bsal

Study which highlighted that Bd had been introduced into Mallorca

Environmental Impact Assessment for housing development

Phyre identified as a resource within ELIXIR UK node servies

News article relating to Imperial research

Companies House incorporation of Neuroprotexeon Limited